Cryo-Cell International Inc (CCEL) stock
CCELNYSEServices-Misc Health & Allied Services, NECFiscal year ends November 30
$4.85−0.55 (-10.19%)
Close on Nov 13, 2026Market cap $39.10MP/E –Yield –
Cryo-Cell International ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Cryo-Cell International's ebitda for the twelve months ending Aug 31, 2026 was $1.05M, down 79.9% year over year. For fiscal 2025 it was $1.47M, down 64.8% from the year before. Over ten years it grew -7.0% a year on average. The highest annual figure on record is $8.03M in fiscal 2020.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $1.47M | -64.8% |
| FY2024 | Nov 30, 2024 | $4.17M | – |
| FY2023 | Nov 30, 2023 | -$10.90M | -297.4% |
| FY2022 | Nov 30, 2022 | $5.52M | +9.2% |
| FY2021 | Nov 30, 2021 | $5.06M | -37.0% |
| FY2020 | Nov 30, 2020 | $8.03M | +47.0% |
| FY2019 | Nov 30, 2019 | $5.46M | -0.8% |
| FY2018 | Nov 30, 2018 | $5.51M | +7.2% |
| FY2017 | Nov 30, 2017 | $5.14M | +773.4% |
| FY2016 | Nov 30, 2016 | $588.27K | -80.6% |
| FY2015 | Nov 30, 2015 | $3.03M | +40.5% |
| FY2014 | Nov 30, 2014 | $2.15M | +13.8% |
| FY2013 | Nov 30, 2013 | $1.89M | – |
| FY2012 | Nov 30, 2012 | -$1.51M | -1883.6% |
| FY2011 | Nov 30, 2011 | $84.49K | -97.7% |
| FY2010 | Nov 30, 2010 | $3.64M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Aug 31, 2026 | $2.38M | +14.0% |
| Q2 FY2026CQ2 2026 | May 31, 2026 | $1.38M | -17.9% |
| Q1 FY2026CQ1 2026 | Feb 28, 2026 | $1.01M | -22.6% |
| Q4 FY2025CQ4 2025 | Nov 30, 2025 | -$3.72M | -3040.2% |
| Q3 FY2025CQ3 2025 | Aug 31, 2025 | $2.09M | +31.7% |
| Q2 FY2025CQ2 2025 | May 31, 2025 | $1.68M | +15.9% |
| Q1 FY2025CQ1 2025 | Feb 28, 2025 | $1.30M | +43.7% |
| Q4 FY2024CQ4 2024 | Nov 30, 2024 | $126.65K | – |
| Q3 FY2024CQ3 2024 | Aug 31, 2024 | $1.58M | +9.9% |
| Q2 FY2024CQ2 2024 | May 31, 2024 | $1.45M | +10.9% |
| Q1 FY2024CQ1 2024 | Feb 29, 2024 | $907.27K | -55.8% |
| Q4 FY2023CQ4 2023 | Nov 30, 2023 | -$15.84M | -2145.4% |
| Q3 FY2023CQ3 2023 | Aug 31, 2023 | $1.44M | +16.7% |
| Q2 FY2023CQ2 2023 | May 31, 2023 | $1.31M | -11.2% |
| Q1 FY2023CQ1 2023 | Feb 28, 2023 | $2.05M | +10.0% |
| Q4 FY2022CQ4 2022 | Nov 30, 2022 | $774.44K | – |
| Q3 FY2022CQ3 2022 | Aug 31, 2022 | $1.24M | -33.7% |
| Q2 FY2022CQ2 2022 | May 31, 2022 | $1.47M | -34.8% |
| Q1 FY2022CQ1 2022 | Feb 28, 2022 | $1.87M | +42.7% |
| Q4 FY2021CQ4 2021 | Nov 30, 2021 | -$481.23K | -121.2% |
| Q3 FY2021CQ3 2021 | Aug 31, 2021 | $1.87M | -26.0% |
| Q2 FY2021CQ2 2021 | May 31, 2021 | $2.26M | +26.0% |
| Q1 FY2021CQ1 2021 | Feb 28, 2021 | $1.31M | -2.8% |
| Q4 FY2020CQ4 2020 | Nov 30, 2020 | $2.27M | +24.9% |
| Q3 FY2020CQ3 2020 | Aug 31, 2020 | $2.52M | +23.6% |
| Q2 FY2020CQ2 2020 | May 31, 2020 | $1.80M | +225.3% |
| Q1 FY2020CQ1 2020 | Feb 29, 2020 | $1.34M | +40.3% |
| Q4 FY2019CQ4 2019 | Nov 30, 2019 | $1.82M | -18.7% |
| Q3 FY2019CQ3 2019 | Aug 31, 2019 | $2.04M | +109.9% |
| Q2 FY2019CQ2 2019 | May 31, 2019 | $551.90K | -53.5% |
| Q1 FY2019CQ1 2019 | Feb 28, 2019 | $958.53K | -6.4% |
| Q4 FY2018CQ4 2018 | Nov 30, 2018 | $2.24M | +74.6% |
| Q3 FY2018CQ3 2018 | Aug 31, 2018 | $972.19K | -34.6% |
| Q2 FY2018CQ2 2018 | May 31, 2018 | $1.19M | -3.1% |
| Q1 FY2018CQ1 2018 | Feb 28, 2018 | $1.02M | -10.8% |
| Q4 FY2017CQ4 2017 | Nov 30, 2017 | $1.28M | +162.2% |
| Q3 FY2017CQ3 2017 | Aug 31, 2017 | $1.49M | – |
| Q2 FY2017CQ2 2017 | May 31, 2017 | $1.22M | – |
| Q1 FY2017CQ1 2017 | Feb 28, 2017 | $1.15M | – |
| Q4 FY2016CQ4 2016 | Nov 30, 2016 | $488.37K | – |
See a number that looks wrong?